TWC
CELZ icon

TD Waterhouse Canada’s Creative Medical Technology CELZ Stock Holding History

TD Waterhouse Canada’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$2 – 2325
2025
Q4 		$2 Hold
1
– – ﹤0.01% 2033
2025
Q3 		$3 Hold
1
– – ﹤0.01% 2058
2025
Q2 		$3 Hold
1
– – ﹤0.01% 1987
2025
Q1 		$2 Hold
1
– – ﹤0.01% 1945
2024
Q4 		$2 Hold
1
– – ﹤0.01% 1962
2024
Q3 		$3 Hold
1
– – ﹤0.01% 1899
2024
Q2 		$4 Buy
+1
New +$5 ﹤0.01% 1905

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TD Waterhouse Canada's CELZ Position: Q1 2026 in Review

TD Waterhouse Canada sold out of Creative Medical Technology (CELZ) in Q1 2026, closing a stake of 1 share — an estimated $2 sold.

TD Waterhouse Canada first reported a position in CELZ in Q2 2024 and held it in 7 quarters. The position peaked at $4 in Q2 2024. 11 funds tracked by Wall St. Rank hold CELZ as of Q1 2026.

  • TD Waterhouse Canada reported no remaining Creative Medical Technology position as of Q1 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 1 Creative Medical Technology share in Q1 2026, an estimated $2.
  • TD Waterhouse Canada first reported a position in Creative Medical Technology in Q2 2024 and held it in 7 quarters.
  • TD Waterhouse Canada's Creative Medical Technology position peaked at $4 in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Creative Medical Technology as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.